TNDM
Tandem Diabetes Care Inc
NASDAQ · Health Care
$19.17
+0.23 (+1.21%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 973.98M | 883.91M | 541.62M | 506.05M | 514.02M |
| Net Income | -99,472,839 | -81,246,533 | 62.34M | 48.01M | 63.53M |
| EPS | — | — | — | — | — |
| Profit Margin | -10.2% | -9.7% | 11.5% | 9.5% | 12.4% |
| Rev Growth | +10.2% | +10.2% | +17.8% | -3.6% | +0.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 372.69M | 372.69M | 92.52M | 100.92M | 108.12M |
| Total Equity | 277.20M | 277.20M | 547.63M | 530.92M | 572.70M |
| D/E Ratio | 1.34 | 1.34 | 0.17 | 0.19 | 0.19 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -86,800,578 | -74,834,875 | 117.19M | 116.78M | 104.62M |
| Free Cash Flow | — | — | 65.90M | 47.29M | 46.73M |